US EditionHuntington's Breakthrough May Not Be The Success It Seems, Expert Cautions
AMT-130 gene therapy reduced Huntington's disease progression by 75% in 12 high-dose patients during a three-year trial, offering hope to 8,000 U.K. sufferers.
7 Articles
7 Articles
U.K. scientists slow Huntington's disease for first time
Read: 2 min U.K. researchers said Wednesday they had slowed the progression of the fatal neural condition Huntington’s disease for the first time with a groundbreaking new gene therapy. Some patients who took part in early-stage clinical trials at University College London saw the speed at which their condition developed reduced by 75 per cent after three years, according to uniQure, a gene therapy company based in the Netherlands and the U.S. T…
Experimental therapy was applied in 12 patients and demonstrated the ability to treat the disease in 75%. In other words, the expected decline in one year with Huntington's disease lasted four years to be observed.
republicain-lorrain.fr
A major medical advance has just been announced by British researchers, in the treatment of Huntington's disease, this hereditary and deadly neurological condition. For the first time, gene therapy seems capable of significantly slowing down the progression of the disease.
Coverage Details
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
